We work with BioPharma from early through late phase development to deliver best-in-class positioning and path-to-market strategy

IDEA Pharma is proud to have been involved in the strategic direction of 83 NME launches in the last five years

Our Work

  • Case Study

    Market Shaping in Action

    The IDEA Pharma team was asked to support the strategic positioning of Celgene and Acceleron's phase II asset (luspatercept) across hematologic indications.

    Read more

  • Case Study

    Path-to-Blockbuster by Design

    How IDEA Pharma helped Cymbalta create its own $5 billion sandbox

    Read more

IDEA Pharma is a division of SAI. Our Decision Intelligence approach integrates cross-functional expertise to lead clients in a stepwise process, driving confident decisions that optimize product value